Lv57
1500 积分 2025-10-21 加入
Current status and future trends of the global burden of MASLD
8天前
已完结
The current landscape of nucleic acid therapeutics
12天前
已完结
Lipid nanoparticle technology for therapeutic gene regulation in the liver
12天前
已完结
Lipid nanoparticles for mRNA delivery
12天前
已完结
Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics
12天前
已完结
Lipid Nanoparticle Systems for Enabling Gene Therapies
12天前
已完结
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
12天前
已完结
The Role of MicroRNAs in Cholesterol Efflux and Hepatic Lipid Metabolism
12天前
已完结
MicroRNAs 103 and 107 regulate insulin sensitivity
12天前
已完结
MicroRNAs in metabolism and metabolic disorders
12天前
已完结
皖公网安备34019202002308
